IBB

iShares Biotechnology ETF
*Unless otherwise stated, data provided by FactSet.

IBB Fund Description

IBB tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges.

IBB Factset Analytics Insight

IBB tracks an index of US biotechnology companies listed on the major US exchanges. This includes companies engaged in the research and development of therapeutic treatments but are not focused on the commercialization and mass production of pharmaceutical drugs. This also includes companies that are engaged in the production of tools or systems that enable biotechnology processes. IBB includes companies of all capitalizations, and weights using a modified market-cap methodology. Individual holdings are subject to capping requirements, 8% on the five largest constituents and 4% for the remaining. The index is rebalanced quarterly and fully reconstituted annually in December. Prior to June 21, 2021, the fund was named iShares Nasdaq Biotechnology ETF and tracked the NASDAQ Biotechnology Index.

IBB MSCI ESG Analytics Insight

iShares Biotechnology ETF has an MSCI ESG Fund Rating of A based on a score of 5.87 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. iShares Biotechnology ETF ranks in the 42nd percentile within its peer group and in the 84th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

IBB MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

PERFORMANCE [as of 09/23/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
IBB 2.66% 6.64% 13.39% 28.46% 13.33% 11.65% 18.78%
IBB (NAV) 1.13% 8.39% 14.99% 31.92% 13.79% 12.10% 18.84%
ICE Biotechnology Index -- -- -- -- -- -- --
Thomson Reuters US Biotechnology & Medical Research -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

IBB Summary Data

Blackrock
iShares
02/05/01
Open-Ended Fund
0.45%
$11.15B
$389.66M
0.02%

IBB Portfolio Data

$50.44B
-586.72
7.44
0.13%
09/24/21
267

IBB Index Data

ICE Biotechnology Index
Tiered
Market Cap
Thomson Reuters US Biotechnology & Medical Research

IBB Portfolio Management

0.45%
-0.52%
-0.40%
-0.67%

IBB Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

IBB Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

IBB Factset Analytics Block Liquidity

As of 09/24/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of IBB. IBB is rated a 5 out of 5.

IBB Tradability

2,286,903
$389.66M
2,036,163
$345.39M
0.02%
$0.03
0.01%
0.19% / -0.59%
None
98.00%
50,000
40.72
0.00%
0.11%
85,397
$173.95
5

IBB Sector/Industry Breakdown


IBB
Segment Benchmark
36.30%
42.17%
27.46%
46.79%
9.16%
0.23%
8.53%
--
6.69%
--
2.54%
--
2.34%
5.72%
1.98%
--
1.38%
--
1.00%
--

IBB Countries


IBB
Segment Benchmark
89.28%
100.00%
4.61%
--
2.04%
--
1.96%
--
0.86%
--
0.64%
--
0.22%
--
0.22%
--
0.07%
--
0.05%
--

IBB Regions


IBB
Segment Benchmark
89.28%
100.00%
7.98%
--
2.72%
--
0.02%
--

IBB Economic Development


IBB
Segment Benchmark
99.36%
100.00%
0.64%
--

IBB Performance Statistics

0.95
0.91
0.99
0.93
0.34%
Thomson Reuters US Biotechnology & Medical Research

IBB MSCI ESG Ratings

5.87 / 10
84.14
41.92
--
31.38%
19.80

IBB Benchmark Comparison Holdings

267
261
176
58.33%

IBB Benchmark Comparison Summary


IBB
Segment Benchmark
267
261
$50.44B
$43.30B
-586.72
-58.34
7.44
6.44
0.49%
0.39%
Medium
High

IBB Benchmark Comparison Market Cap Size


IBB
Segment Benchmark
70.25%
58.24%
20.20%
25.73%
7.97%
13.19%
1.58%
2.85%

Options Strategies for Outcome Investing

Options allow you to customize investment outcomes. Using the strategy builders provided by Cboe Vest Technologies, you can construct some of the most common option strategies. Check out our user guide for more information on how to use the tool.

A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security.